OHDSI Digest – February 6th, 2017

OHDSI MEETINGS THIS WEEK
CDM work group meeting – Tuesday at 1pm ET
Webex: https://imshealth.webex.com/mw3000/mywebex/default.do?service=1&siteurl=imshealth&nomenu=true&main_url=%2Fmc3000%2Fe.do%3Fsiteurl%3Dimshealth%26AT%3DMI%26EventID%3D534347467%26UID%3D0%26Host%3DQUhTSwAAAAJGoQPBhYIiWL9gqYIQ2zOyDR1OBuFoZarWuiIBLmsMv-ExtzArDYX5vIh0aHpp6IbrXiuzrzFsvQlqBeYQKPbq0%26FrameSet%3D2%26MTID%3Dm8728276b244be469f2b94609b2e68657
Meeting number: 738 554 364
Meeting password: OMOP
Join by phone
US: 610-244-3377
US toll-free: 855-633-8467
UK: +44-203-075-5950
DE: +49-69-6604-4065
Conference ID: 14916110
Host PIN: 6110

Pharmacovigilance evidence investigation (LAERTES) Workgroup – Tuesday at 3pm ET
Please join my meeting:
https://global.gotomeeting.com/join/530277469
Or, call in using your telephone:
United States: +1 (224) 501-3217
Sweden: +46 (0) 853 527 83
Access Code: 530-277-469

Patient-Level prediction work group meeting (West) – Wednesday at 12pm ET
https://global.gotomeeting.com/join/972917661

NLP work group meeting – Wednesday at 3pm ET
Screen Sharing: https://global.gotomeeting.com/join/707196421
Dial +1 (571) 317-3122 (United States)
Enter conference ID: 707-196-421

Architecture WG meeting – Thursday at 1pm ET
Webex: https://jjconferencing.webex.com/mw3000/mywebex/default.do?service=1&main_url=%2Fmc3000%2Fe.do%3Fsiteurl%3Djjconferencing%26AT%3DMI%26EventID%3D283835502%26MTID%3Dmb7e839a762fbdaab0608f27500679223%26Host%3DQUhTSwAAAAJeWdHi8LngOQ9smApIpbVefhBBenkejOWGXHugpWO1FS9D3MOVZippskL4ZSabmOUGCl_S82DbDobKaieECNwY0%26FrameSet%3D2&siteurl=jjconferencing&nomenu=true

ANNOUNCEMENTS
OHDSI F2F – Registration is now open for the OHDSI F2F to take place on March 17-18th at GeorgiaTech in Atlanta. Register here:
http://www.ohdsi.org/events/2017-ohdsi-collaborator-face-to-face/

People will forget what you said, people will forget what you did, but people will never forget how you made them feel
– Maya Angelou

COMMUNITY PUBLICATIONS
New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies
http://www.sciencedirect.com/science/article/pii/S0968089616309592

Multisite Evaluation of a Data Quality Tool for Patient-Level Clinical Data Sets.
https://www.ncbi.nlm.nih.gov/pubmed/28154833

Furvina inhibits the 3-oxo-C12-HSL-based quorum sensing system of Pseudomonas aeruginosa and QS-dependent phenotypes.
https://www.ncbi.nlm.nih.gov/pubmed/28140677

Posted in Uncategorized